Ascom’s ClinicalConneX Achieves FDA Clearance

February 28, 2011 No Comments

SOURCE:  Ascom

Ascom (NewsAlert) (US) Inc., a leading supplier of mission critical on-site wireless communications, is pleased to announce ClinicalConneX as its new integration suite powered by Ascom’s Unite Professional Messaging and Alarm Application. ClinicalConneX | Cardiomax is the first Ascom medical device cleared by the United States Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH).

Cardiomax is a component within the ClinicalConneX integration suite and provides an interface to Patient Monitoring Systems that forward alarm information to Ascom handsets or a wide variety of display devices, including pagers, mobile handsets and LED signs. It provides near real time alarms intended to serve as a parallel, redundant, forwarding mechanism to inform healthcare professionals of particular medical related events captured by Patient Monitoring Systems. The display device can provide a combination of visual, audio and vibratory awareness mechanisms upon receipt of the secondary alert notification. ClinicalConneX | Cardiomax has been designed to integrate with a variety of both standards-based and proprietary Patient Monitoring Systems.

View Press Release

HEALTH IT, News

Leave a Reply

(required)

(required)


ADVERTISEMENT

AnDevCon


American Customer Festival 2016 New York

ITBriefcase Comparison Report

Cyber Security Exchange